A. Nagler

发表

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia

P. Vyas, J. Bourhis, C. Craddock, 2018, Journal of internal medicine.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

J. Radich, H. Kantarjian, D. B. Yehuda, 2013, Blood.

Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission

M. Labopin, A. Nagler, M. Mohty, 2016, Bone Marrow Transplantation.

Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective

A. Nagler, A. Olivieri, N. Shem-Tov, 2015, Bone Marrow Transplantation.

Optimizing the Pretransplant Regimen for Autologous Stem Cell Transplantation in Acute Myelogenous Leukemia : Better Outcomes with Busulfan and Melphalan Compared with Busulfan and Cyclophosphamide in High Risk Patients Autografted in First Complete Remission

M. Labopin, D. Blaise, M. Mohty, 2017 .

P O B O X 1 1 7 2 2 1 0 0 L U N D + 4 6 4 6 -2 2 2 0 0 0 0

J. Esteve, M. Labopin, I. Yakoub-Agha, 2022 .

The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia.

A. Nagler, S. Slavin, G. Váradi, 1999, Leukemia research.

Heparanase enhances myeloma progression via CXCL10 downregulation

A. Nagler, K. Beider, I. Vlodavsky, 2014, Leukemia.

An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients

A. Nagler, A. Nagler, A. Toren, 2010, Infection.

High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group

K. Sułek, R. Dziadziuszko, A. Nagler, 2002, Bone Marrow Transplantation.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Francisco Cervantes, Ryuzo Ohno, Richard E. Clark, 2013, Blood.

Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT

M. Labopin, M. Mohty, M. Itälä-Remes, 2024, Blood advances.

Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta).

A. Nagler, H. Emonard, F. Levi-Schaffer, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party

E. Tholouli, J. Snowden, J. Finke, 2023, Bone marrow transplantation.

The soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro maintenance and proliferation of human CD34(+)CD38(-/low) cells capable of repopulating severe combined immunodeficiency mice.

A. Nagler, H. Ben‐Hur, O. Kollet, 1999, Blood.

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3

J. Wingard, A. Mishra, M. Levis, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC)

A. Nagler, R. Condiotti, M. Nguyen, 1999, Medical oncology.

Impact of the type of tyrosine kinase inhibitor (imatinib or dasatinib) used before allo-HCT on outcome of patients with Philadelphia-positive acute lymphoblastic leukemia. A study on behalf of the Acute Leukemia Working Party of the EBMT.

M. Labopin, M. Mohty, U. Salmenniemi, 2024, Transplantation and cellular therapy.

P O B O X 1 1 7 2 2 1 0 0 L U N D + 4 6 4 6 -2 2 2 0 0 0 0

J. Esteve, C. Craddock, M. Labopin, 2022 .

Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.

M. Labopin, D. Blaise, M. Mohty, 2024, Cancer.

Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.

M. Mohty, F. Bonifazi, Z. Perić, 2024, The Lancet. Haematology.

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

R. Porcher, G. Mufti, C. Craddock, 2017, Bone Marrow Transplantation.

Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis in HLA-matched and haploidentical donor transplants for patients with Hodgkin lymphoma: a comparative study of the LWP EBMT.: GVHD prophylaxis for patients with Hodgkin lymphoma.

J. Pérez-Simón, L. Castagna, A. Dominietto, 2023, Transplantation and cellular therapy.

Haploidentical transplantation in primary refractory/relapsed secondary vs de novo AML: from the ALWP/EBMT

M. Labopin, M. Mohty, E. Forcade, 2024, Blood advances.

Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study

F. Baron, M. Mohty, F. Ciceri, 2023, British journal of haematology.

Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT

M. Labopin, D. Blaise, M. Mohty, 2023, Journal of Hematology & Oncology.

Thiotepa-based regimens are a valid alternative to total body irradiation-based reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia: a retrospective study on behalf of the Acute Leukemia Working Party of the EBMT.

M. Labopin, M. Mohty, A. Spyridonidis, 2023, Transplantation and cellular therapy.

Staphylococcus aureus bacteremia and endocarditis: comparison of nosocomial and community-acquired infection.

J. Sobel, A. Nagler, R. Finkelstein, 1984, Journal of medicine.

Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide.

M. Labopin, M. Mohty, A. Bazarbachi, 2024, Leukemia.

PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT

J. Pérez-Simón, I. Sakellari, P. Matteucci, 2024, Blood advances.

Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients

M. Mohty, A. Bazarbachi, M. Bornhäuser, 2024, Blood cancer journal.